Cradle Bio vs Karius

Side-by-side comparison of AI visibility scores, market position, and capabilities

Karius leads in AI visibility (73 vs 35)
Cradle Bio logo

Cradle Bio

EmergingLife Sciences & BioTech

AI Protein Engineering

Cradle provides an AI platform for protein engineering that accelerates the design of improved enzymes, antibodies, and other biologics for industrial and therapeutic use.

AI VisibilityBeta
Overall Score
D35
Category Rank
#120 of 198
AI Consensus
91%
Trend
stable
Per Platform
ChatGPT
38
Perplexity
36
Gemini
36

About

Cradle Bio is an AI protein engineering company founded in 2021 in Amsterdam, having raised $73M to build an AI-powered protein design platform. The platform combines generative AI with wet-lab experimentation to accelerate the iterative process of engineering proteins with improved stability, activity, and manufacturability. Cradle's technology enables researchers to design thousands of protein variants computationally and prioritize those most likely to succeed in laboratory validation, compressing protein engineering timelines from years to months. The company serves both industrial biotechnology customers engineering enzymes for biomanufacturing and pharmaceutical companies developing next-generation antibody therapeutics. Cradle partners with contract research organizations and biopharmaceutical companies to integrate AI-assisted protein design into existing discovery workflows. The company has been recognized as a leader in the European deep tech ecosystem and positions protein engineering AI as enabling a new era of designed biologics for medicine and sustainable manufacturing.

Full profile
Karius logo

Karius

LeaderLife Sciences & BioTech

Genomic Infectious Disease Diagnostics

Karius raised $409M total including a $100M Series C in May 2024; its genomic blood test detects 1,000+ pathogens at 400+ U.S. hospitals; launched Karius Focus BAL for pneumonia in April 2025.

AI VisibilityBeta
Overall Score
B73
Category Rank
#12 of 198
AI Consensus
78%
Trend
stable
Per Platform
ChatGPT
69
Perplexity
70
Gemini
70

About

Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens (bacteria, fungi, viruses, parasites) in seriously ill patients. The test is used when conventional cultures and targeted diagnostics fail, providing clinicians at transplant centers, children''s hospitals, and ICUs with a comprehensive pathogen report within 24 hours.

Full profile

AI Visibility Head-to-Head

35
Overall Score
73
#120
Category Rank
#12
91
AI Consensus
78
stable
Trend
stable
38
ChatGPT
69
36
Perplexity
70
36
Gemini
70
35
Claude
75
34
Grok
77

Key Details

Category
AI Protein Engineering
Genomic Infectious Disease Diagnostics
Tier
Emerging
Leader
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Cradle Bio
AI Protein Engineering

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.